Santoni M.; Conti A.; Partelli S.; Porta C.; Sternberg C.N.; Procopio G.; Bracarda S.; Basso U.; De Giorgi U.; Derosa L.; Rizzo M.; Ortega C.; Massari F.; Iacovelli R.; Milella M.; Di Lorenzo G.; Buti S.; Cerbone L.; Burattini L.; Montironi R.; Santini D.; Falconi M.; Cascinu S., Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors, «ANNALS OF SURGICAL ONCOLOGY», 2015, 22, pp. 2094 - 2100 [Scientific article]
Massari F.; Ciccarese C.; Santoni M.; Lopez-Beltran A.; Scarpelli M.; Montironi R.; Cheng L., Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma, «EXPERT REVIEW OF ANTICANCER THERAPY», 2015, 15, pp. 1367 - 1369 [Scientific article]
Massari F.; Santoni M.; Ciccarese C.; Santini D., The immunocheckpoints in modern oncology: The next 15 years, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2015, 15, pp. 917 - 921 [Scientific article]
Santoni M.; Piva F.; Scarpelli M.; Cheng L.; Lopez-Beltran A.; Massari F.; Iacovelli R.; Berardi R.; Santini D.; Montironi R., The origin of prostate metastases: emerging insights, «CANCER METASTASIS REVIEWS», 2015, 34, pp. 765 - 773 [Scientific article]
Massari F.; Ciccarese C.; Santoni M.; Brunelli M.; Conti A.; Modena A.; Montironi R.; Santini D.; Cheng L.; Martignoni G.; Cascinu S.; Tortora G., The route to personalized medicine in bladder cancer: where do we stand?, «TARGETED ONCOLOGY», 2015, 10, pp. 325 - 336 [Scientific article]
Santoni M.; Conti A.; Massari F.; Arnaldi G.; Iacovelli R.; Rizzo M.; De Giorgi U.; Trementino L.; Procopio G.; Tortora G.; Cascinu S., Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials, «INTERNATIONAL JOURNAL OF CANCER», 2015, 136, pp. 1 - 10 [Scientific article]
Massari F.; Ciccarese C.; Modena A.; Maines F.; Segala D.; Luchini C.; Marcolini L.; Cavicchioli F.; Cavalleri S.; Bria E.; Brunelli M.; Martignoni G.; Artibani W.; Tortora G., Adenocarcinoma of the paraurethral glands: A case report, «HISTOLOGY AND HISTOPATHOLOGY», 2014, 29, pp. 1295 - 1303 [Scientific article]
Pilotto S.; Bonomi M.; Massari F.; Milella M.; Ciuffreda L.; Brunelli M.; Fassan M.; Chilosi M.; Scarpa A.; Tortora G.; Bria E., Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: A 'hard days night', «CURRENT PHARMACEUTICAL DESIGN», 2014, 20, pp. 3958 - 3972 [Scientific article]
Santoni M.; Bracarda S.; Nabissi M.; Massari F.; Conti A.; Bria E.; Tortora G.; Santoni G.; Cascinu S., CXC and CC chemokines as angiogenic modulators in nonhaematological tumors, «BIOMED RESEARCH INTERNATIONAL», 2014, 2014, Article number: 768758 , pp. 1 - 12 [Scientific article]
Santoni M.; Santini D.; Massari F.; Conti A.; Iacovelli R.; Burattini L.; Tortora G.; Falconi M.; Montironi R.; Cascinu S., Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: Suggestions from bench to bedside, «CANCER METASTASIS REVIEWS», 2014, 33, pp. 321 - 331 [Scientific article]
Fiorini C.; Massari F.; Pedron S.; Sanavio S.; Ciccarese C.; Porcaro A.B.; Artibani W.; Bertoldo F.; Zampini C.; Sava T.; Ficial M.; Calio A.; Chilosi M.; D'Amuri A.; Sanguedolce F.; Tortora G.; Scarpa A.; Delahunt B.; Porta C.; Martignoni G.; Brunelli M., Methods to identify molecular expression of mTOR pathway: A rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors, «AMERICAN JOURNAL OF CANCER RESEARCH», 2014, 4, pp. 907 - 915 [Scientific article]
Pilotto S.; Di Maio M.; Peretti U.; Kinspergher S.; Brunelli M.; Massari F.; Sperduti I.; Giannarelli D.; De Marinis F.; Tortora G.; Bria E., Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2014, 90, pp. 135 - 145 [Scientific article]
Massari F.; Ciccarese C.; Porcaro A.B.; Ferrero S.; Gazzano G.; Artibani W.; Modena A.; Bria E.; Sava T.; Calio A.; Novara G.; Ficarra V.; Chilosi M.; Martignoni G.; Bosari S.; Cheng L.; Tortora G.; Brunelli M., Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma, «PATHOLOGY», 2014, 46, pp. 523 - 526 [Scientific article]
Bianconi M.; Santoni M.; Massari F.; Faloppi L.; Prete M.D.; Giampieri R.; Ciccarese C.; Modena A.; Tortora G.; Scartozzi M.; Cascinu S., Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice, «FUTURE ONCOLOGY», 2014, 10, pp. 2103 - 2106 [Scientific article]
Massari F.; Bria E.; Maines F.; Milella M.; Giannarelli D.; Cognetti F.; Pappagallo G.; Tortora G.; Porta C., Adjuvant treatment for resected renal cell carcinoma: Are all strategies equally negative? Potential implications for trial design with targeted agents, «CLINICAL GENITOURINARY CANCER», 2013, 11, pp. 471 - 476 [Scientific article]
